RadNet earnings slip, volume rises

Article

Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008.

Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008. For the three months ended Sept. 30, 2009, RadNet reported revenue of $133.4 million versus $130.9 million in 3Q 2008 and a loss of $1.7 million compared with net income of $138,000. On a same-center basis, including only centers that were part of RadNet for both the third quarters of 2009 and 2008, MRI volume increased 5.4%, CT volume increased 4.0%, and PET/CT volume increased 4.3%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 3.2% over the same quarter in the prior year.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.